What Is a Mitoceutical?

Reviewed by SOMA HEALTH's Medical Research Team

The word mitoceutical is newer than the science behind it. It describes a compound chosen specifically for how it acts on mitochondria, the tiny structures inside your cells that turn food and oxygen into usable energy. Urolithin A is one of the more carefully studied examples, and understanding the category helps explain why.

Defining the term

A mitoceutical is best understood as a nutraceutical, meaning a nutritional or naturally derived compound, whose intended target is mitochondrial function. The label is not a formal regulatory or medical classification; it is a practical way to group ingredients by mechanism rather than by the body part or symptom they are marketed toward. Where a general antioxidant is described by what it neutralizes, a mitoceutical is described by where it works.

To see why mitochondria are worth targeting, it helps to recall what they do. Inside nearly every cell, mitochondria run a process called oxidative phosphorylation that generates the bulk of your cellular energy currency, ATP. They are especially concentrated in tissues with high energy demands, such as muscle, heart, and brain. As we age, or under stress, mitochondria can become less efficient and accumulate damage. The body has quality-control systems to manage this, and one of them, mitophagy, is central to the mitoceutical idea.

How compounds target mitochondria

Different mitoceuticals engage mitochondria in different ways, and it is worth being precise rather than lumping them together.

Cofactors and building blocks

Some compounds act as raw materials or cofactors in energy production. Coenzyme Q10 (CoQ10) is a carrier in the electron transport chain, the assembly line that produces ATP. PQQ (pyrroloquinoline quinone) has been studied in the context of mitochondrial biogenesis, the making of new mitochondria. NAD precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) aim to support NAD+, a molecule involved in many energy-related reactions. Each of these has its own evidence base, and none should be assumed equivalent to the others. Our comparison notes on NAD-related ingredients live in the wider urolithin A guide.

Quality-control compounds

A different strategy is to support the cell's recycling machinery rather than feed the assembly line. This is where urolithin A sits. Rather than acting as fuel, it has been studied for its ability to promote mitophagy, the process by which cells identify worn-out or damaged mitochondria and break them down so their parts can be recycled and healthier mitochondria can take over. You can read a fuller explanation in our piece on what mitophagy is.

Where urolithin A fits, with the evidence labeled

Urolithin A is a gut postbiotic. It is not present in food directly; instead, certain gut bacteria produce it from ellagitannins found in pomegranate, walnuts, and berries. Because only some people carry the bacteria needed to make it efficiently, the finished compound is often taken as a supplement.

Proven in humans

Human research on urolithin A is unusually developed for a compound in this space. The first-in-human trial by Andreux and colleagues (Nature Metabolism, 2019) reported that oral urolithin A was safe and well tolerated up to 1,000 mg per day and produced a mitochondrial gene-expression signature in older adults. Liu, D'Amico and colleagues (JAMA Network Open, 2022) reported improvements in muscle endurance in older adults over about four months. Singh and colleagues (Cell Reports Medicine, 2022) tested 500 mg and 1,000 mg daily over four months in middle-aged adults and reported effects on muscle strength and exercise performance.

Newer human research

More recent trials continue the theme. A 2024 randomized study in the Journal of the International Society of Sports Nutrition looked at resistance-trained men over eight weeks, and a 2025 randomized controlled trial in Nature Aging reported that urolithin A supported immune-cell mitochondrial health in midlife adults over roughly 28 days, work tied to the concept of inflammaging. A 2024 systematic review in Ageing Research Reviews concludes, sensibly, that the human evidence is encouraging but still emerging.

Preclinical foundations

The mechanistic groundwork is preclinical and should be labeled as such. Ryu and colleagues (Nature Medicine, 2016) demonstrated that urolithin A triggered mitophagy, extended lifespan in C. elegans, and improved muscle function in rodents. Preclinical research is also exploring joint and cartilage biology (D'Amico and colleagues, Aging Cell, 2022) and is at an early stage in tissues such as skin, gut, brain, and heart. These findings guide hypotheses but are not confirmed human benefits.

How to think about the category

The mitoceutical framing is useful precisely because it keeps the focus on mechanism and evidence quality rather than marketing. A few principles help. First, look at whether a compound has been studied in humans, not only in cells or animals, and at what dose. Second, remember that different mitoceuticals do different jobs; a cofactor like CoQ10 and a mitophagy-focused compound like urolithin A are not interchangeable, and stacking is not automatically better. Third, be wary of sweeping anti-aging language. The honest reading of the current science, including for urolithin A, is that human benefits observed so far are meaningful but still being confirmed in larger, longer studies.

Mitoceuticals are supplements that support normal structure and function; they are not treatments for any disease or condition, and they are not a substitute for medical care. If you have a diagnosed condition affecting energy, muscle, or metabolism, please talk with your doctor before adding any supplement. For dose specifics, see our overview of urolithin A dosage, and for the shopping side, our roundup of the best urolithin A gummies.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.